Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.

measured within 16 h of infusion completion was significantly associated with the development of AKI and serves as an early clearance biomarker that may identify patients who benefit from increased hydration, augmented leucovorin rescue, and glucarpidase administration.